FATE Bull Call Spread Strategy
FATE (Fate Therapeutics, Inc.), in the Healthcare sector, (Biotechnology industry), listed on NASDAQ.
Fate Therapeutics, Inc. is a clinical-stage biopharmaceutical firm dedicated to creating advanced, programmed cellular immunotherapies. These innovative treatments are designed to combat cancer and various immune disorders across the globe. A significant portion of its development pipeline concentrates on NK- and T-cell immuno-oncology programs. Key candidates include FT516, which targets acute myeloid leukemia (AML), B-cell lymphoma, and advanced solid tumors; FT596 for B-cell lymphoma and chronic lymphocytic leukemia; FT538, addressing AML and multiple myeloma; FT576, also focused on multiple myeloma; FT819, aimed at both hematologic malignancies and solid tumors; FT536, another program for solid tumors; and FT500, intended for advanced solid tumors. The company also actively engages in strategic collaborations to advance its research and development. It holds an agreement with Ono Pharmaceutical Co.
FATE (Fate Therapeutics, Inc.) trades in the Healthcare sector, specifically Biotechnology, with a market capitalization of approximately $244.8M, a beta of 2.52 versus the broader market, a 52-week range of 0.91-2.88, average daily share volume of 3.2M, a public-listing history dating back to 2013, approximately 181 full-time employees. These structural characteristics shape how FATE stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 2.52 indicates FATE has historically moved more than the broader market, amplifying both the directional payoff and the realized volatility relative to an index-equivalent position.
What is a bull call spread on FATE?
A bull call spread buys an at-the-money call and sells an out-of-the-money call at a higher strike for defined risk and defined reward bounded by the strike width.
Current FATE snapshot
As of June 30, 2026, spot at $2.66, ATM IV 158.80%, IV rank 29.54%, expected move 45.53%. The bull call spread on FATE below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 17-day expiry.
Why this bull call spread structure on FATE specifically: FATE IV at 158.80% is on the cheap side of its 1-year range, which favors premium-buying structures like a FATE bull call spread, with a market-implied 1-standard-deviation move of approximately 45.53% (roughly $1.21 on the underlying). The 17-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated FATE expiries trade a higher absolute premium for lower per-day decay. Position sizing on FATE should anchor to the underlying notional of $2.66 per share and to the trader's directional view on FATE stock.
FATE bull call spread setup
The FATE bull call spread below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With FATE near $2.66, the first option leg uses a $2.66 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed FATE chain at a 17-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 FATE shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Buy 1 | Call | $2.66 | N/A |
| Sell 1 | Call | $2.79 | N/A |
FATE bull call spread risk and reward
- Net Premium / Debit
- N/A
- Max Profit (per contract)
- Unbounded
- Max Loss (per contract)
- Unbounded
- Breakeven(s)
- None on modeled curve
- Risk / Reward Ratio
- N/A
Max profit equals strike width minus net debit times 100; max loss equals net debit times 100. Breakeven is long-call strike plus net debit.
FATE bull call spread payoff curve
Modeled P&L at expiration across a range of underlying prices for the bull call spread on FATE. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
When traders use bull call spread on FATE
Bull call spreads on FATE reduce the cost of a bullish FATE stock position by selling a higher-strike call; suited to moderate-move theses where price reaches but does not vastly exceed the short strike.
FATE thesis for this bull call spread
The market-implied 1-standard-deviation range for FATE extends from approximately $1.45 on the downside to $3.87 on the upside. A FATE bull call spread caps both the risk and the reward of a bullish position; relative to an outright long call on FATE, the spread reduces the cost basis but limits the maximum profit to the strike width minus net debit. Current FATE IV rank near 29.54% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on FATE at 158.80%. As a Healthcare name, FATE options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to FATE-specific events.
FATE bull call spread positions are structurally moderately bullish; the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. FATE positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move FATE alongside the broader basket even when FATE-specific fundamentals are unchanged. Long-premium structures like a bull call spread on FATE are particularly exposed to IV-crush risk through scheduled events (earnings, FDA decisions, central-bank meetings) where IV typically contracts post-event regardless of the directional outcome. Always rebuild the position from current FATE chain quotes before placing a trade.
Frequently asked questions
- What is a bull call spread on FATE?
- A bull call spread on FATE is the bull call spread strategy applied to FATE (stock). The strategy is structurally moderately bullish: A bull call spread buys an at-the-money call and sells an out-of-the-money call at a higher strike for defined risk and defined reward bounded by the strike width. With FATE stock trading near $2.66, the strikes shown on this page are snapped to the nearest listed FATE chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
- How are FATE bull call spread max profit and max loss calculated?
- Max profit equals strike width minus net debit times 100; max loss equals net debit times 100. Breakeven is long-call strike plus net debit. For the FATE bull call spread priced from the end-of-day chain at a 30-day expiry (ATM IV 158.80%), the computed maximum profit is unbounded per contract and the computed maximum loss is unbounded per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a FATE bull call spread?
- The breakeven for the FATE bull call spread priced on this page is no defined breakeven on the modeled curve at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current FATE market-implied 1-standard-deviation expected move is approximately 45.53%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a bull call spread on FATE?
- Bull call spreads on FATE reduce the cost of a bullish FATE stock position by selling a higher-strike call; suited to moderate-move theses where price reaches but does not vastly exceed the short strike.
- How does current FATE implied volatility affect this bull call spread?
- FATE ATM IV is at 158.80% with IV rank near 29.54%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.